Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 1
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Epidemiology and outcomes
Original research
Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study
Online download statistics by month:
Online download statistics by month: November 2022 to February 2024
Abstract
Full
Pdf
Nov 2022
72
65
10
Dec 2022
342
340
162
Jan 2023
246
244
39
Feb 2023
123
122
51
Mar 2023
81
78
63
Apr 2023
71
65
46
May 2023
64
61
26
Jun 2023
85
83
16
Jul 2023
53
52
25
Aug 2023
88
85
15
Sep 2023
52
52
17
Oct 2023
54
50
13
Nov 2023
157
156
18
Dec 2023
59
58
33
Jan 2024
62
62
21
Feb 2024
52
51
15
Total
1661
1624
570
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?